Ivermectin shows clinical benefits in mild to moderate COVID19: RCT double-blind

Re:Ivermectin shows clinical benefits in mild to moderate CO... by bratao on Sunday September 05, 2021 @05:09PM (#28427823)

"Sample size: A convenient sample size of 60 with 20 in each arm, was planned. However, 62 were ultimately randomized."

Sounds very underpowered

[ Parent | on HN ]

Re:Ivermectin shows clinical benefits in mild to moderate CO... by throwaway224466 on Sunday September 05, 2021 @05:38PM (#28428051)

And yet every study backing up the efficacy and safety of the covid vaccine for particular subsets has around 20 total participants, often times with an invalid control group in place....but I'm sure you eat that up and share away

[ Parent | on HN ]

Re:Ivermectin shows clinical benefits in mild to moderate CO... by im-poor on Sunday September 05, 2021 @05:42PM (#28428091)

I believe Moderna’s Phase 3 involved 30,000 people, just FYI.

[ Parent | on HN ]

[dead]

Re:Ivermectin shows clinical benefits in mild to moderate CO... by im-poor on Sunday September 05, 2021 @06:08PM (#28428264)

The government publishes all of the results. You can take a look yourself: https://clinicaltrials.gov/ct2/show/NCT04470427

There are a lot of studies done on small sample sizes. It some sense it’s necessary: if something is unsafe on a small sample, it’s more than likely unsafe on a large sample.

[ Parent | on HN ]